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Mathematical modeling is a promising approach to reveal disease-related regulatory mechanisms. This article
gives an overview of how mathematical modeling can increase our understanding of skin disease, addressing
both its benefits and challenges. We discuss the importance of strong links among experiments, mathematical
modeling, and data analysis in order to effectively use the modeling approach to advance skin research in the
postgenomic era. Investigative dermatologists are needed to drive and orient this cross-disciplinary research to
address fundamental problems in skin biology and disease.
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INTRODUCTION: WHY A
MATHEMATICAL PERSPECTIVE?
The past 20 years have witnessed a
dramatic increase in our knowledge of
the molecular mechanisms of skin dis-
eases, leading to improvements in diag-
nosis and treatment (O’Toole, 2010;
Uitto et al., 2012). Technological
advances, such as microarray and
deep sequencing for transcriptomic
analysis, enable simultaneous quanti-
tative measurements of the expression
and activity of effectively all the
components in the tissue (Ideker et al.,
2001) in normal and disease conditions
(Strohman, 2002). However, these
quantitative measurements are snap-
shots and only capture a small part of
the entire process. How are these
snapshots related to each other and
how does the amount of each
molecule change over time?
Skin is a highly dynamic tissue with
continually renewing epidermis and
ever-surveilling immune cells. Appropri-
ate functioning of the regulatory
mechanisms built into the system main-
tains homeostasis, and malfunction of
the regulatory mechanisms may result in
disease. Understanding the disease state
is thus equivalent to understanding the
disease-related regulatory mechanisms.
Mathematical modeling offers a means
for understanding and describing
these dynamic regulatory mechanisms
(Vodovotz et al., 2008; Auffray
et al., 2009; Hunter and Viceconti,
2009). Mathematically explicit and
quantitative descriptions of the dyna-
mics of the system, coupled with experi-
ments, can reveal hidden regulatory
mechanisms that cannot be revealed
by conventional experimental methods.
Mathematical models will also be
useful for personalized treatments in
future. For example, model simulation
using the data of an individual patient
at several times may effectively reveal
the characteristics of the patient
and enable optimal administration of
drugs for the treatment of malignant
tumor and viral infection (Cambiano
and Phillips, 2011; Luo et al., 2011;
Hirata et al., 2012).
STEPS TO MODEL SKIN DISEASE
FROM A MATHEMATICAL
PERSPECTIVE
This section illustrates the different steps
in the modeling approach, with a math-
ematical model of atopic dermatitis
(AD) (Tanaka et al., 2011), designated
as ‘‘the AD model’’ hereafter, as a
specific example (Figure 1). Although
we focus on the modeling from
the control engineering perspective,
the most effective modeling
approach may vary for each biological
problem.
Definition of the target and hypothesis
Modeling skin disease begins with
defining the system to be modeled and
the hypothesis to be examined. This step
requires a sufficient knowledge of both
experimental systems and modeling
methods, and collaboration between
experimental researchers and mathema-
tical modelers is indispensable from the
very beginning, as biological knowledge
of the target disease is essential to
identify the subsystems to be modeled.
The modeling approach is most effective
in revealing the regulatory relationships
among well-characterized molecules
and in analyzing general features of a
skin disease.
The AD model was developed to
reveal the regulatory mechanism for
the barrier homeostasis and its relation
to inflammation in AD. We defined the
hypothesis that a positive feedback
mechanism that regulates the activity
of protease kallikreins (KLKs) produces
the outbreak and persistence of inflam-
mation in AD (Figure 1a), based on the
observations that barrier dysfunction
and immune dysregulation contribute
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to the development of AD (Denda et al.,
1998; Leung, 2000; Cork et al., 2009)
and that the excessive activity of KLKs
increases skin desquamation, resulting
in barrier dysfunction and eczema
(Voegeli et al., 2009).
Model development
Determine the system outputs and inputs.
To develop a mathematical model, the
outputs and inputs of the system should
be clearly identified. The outputs corre-
spond to the major outcome of the dysre-
gulation of the system that drives the
disease process. They correlate with dis-
ease activity and are primarily monitored
for the disease treatment. Generally, the
inputs trigger the disease activity through
the internal regulatory mechanisms,
although the symptoms can also be trig-
gered without explicit inputs but by inter-
nal dysregulation.The output and the input
of the AD model were defined as the
inflammation mediated by protease-acti-
vated receptor 2 (PAR2) and the external
stimulus that triggers the inflammation,
respectively (Figure 1b), as KLKs activate
PAR2 on the surface of keratinocytes
causing inflammation (Rattenholl and
Steinhoff, 2003; Cork et al., 2009) and
PAR2 activation is the most proximal to
epidermal dysregulation in a series of
inflammatory events.
Determine the system structure for regula-
tory mechanisms. The model structures
(e.g., mechanistic and physical interac-
tions between the components) are deter-
mined based on previous biological
studies. Obviously, the model should
include the key components so that the
model results are clinically or biologically
relevant and can be compared
with experimental results. Models
should be as simple as possible, yet as
complex as necessary to address the spe-
cific question of interest (Garny et al.,
2005). This tradeoff determines the
difficulty in validation, analysis, and inter-
pretation. The AD model includes a
protease inhibitor of KLKs, lympho-
epithelial Kazal-type-related inhibitor
(LEKTI), because it is a causal gene of a
genetic skin disease, Netherton syndrome,
and the uncontrolled KLK activity in
Netherton syndrome epidermis triggers
AD-like lesions (Briot et al., 2009). The
AD model contains a minimal number
of components, avoiding unnecessary
complexity, while still capturing the
essential characteristics of inflammation
in AD (Figure 1c).
Translate into mathematical description
and find parameters. Regulatory
mechanisms can be described by different
mathematical tools, including differential
equations, agent-based models, Petri nets,
and cellular automata (Materi and
Wishart, 2007; Machado et al., 2011).
The most effective tool varies for each
biological problem. The value ranges for
model parameters, such as decay rates and
reaction rates, should be estimated by the
experimental data. For the AD model, the
reactions and interactions between KLKs,
PAR2, and LEKTI were translated into
ordinary differential equations and the
value ranges for the parameters were
taken from the literature.
Model analysis
Once the model is developed, its ana-
lysis is carried out mathematically. Ide-
ally, the model will predict the
future behavior of the system, identify
the possible dysregulation points
(i.e., changes in model structures
and parameters), predict the effects of
interventions, and test conditions that
are difficult to be realized experi-
mentally.
For example, bifurcation analysis is
an analytical method to investigate the
relationship between parameter values
and the steady states (the state that the
system reaches after long time; e.g.,
when drug effects are stabilized). Time
course analysis by computer simulation
may reveal nonintuitive dynamics of
each component in the system.
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Figure 1. Key steps in mathematical modeling of atopic dermatitis (AD). (a) A target of the modeling was identified as the regulatory system of kallikrein (KLK)
activity. A hypothesis was formed that a positive feedback mechanism that regulates KLK activity captures the essential features of AD. (b) The systems inputs and
outputs were determined. In this case, external environmental stimuli are the inputs that lead to KLK activation. In normal healthy homeostasis, the output is a
disease-free state, whereas in AD, excessive activation of KLKs leads to inflammation. (c) The minimal network of interactions between the KLK inhibitor LEKTI
(lympho-epithelial Kazal-type-related inhibitor), KLKs, and protease-activated receptor 2 (PAR2) was described by a simple diagram as shown, and were translated
into a system of ordinary differential equations. This comprised the mathematical model. KLK* and PAR2* represent the activated forms of KLK and PAR2,
respectively. (d) The relationship between the input (external stimulus, abscissa) and the output (PAR2-mediated inflammation, ordinate) was obtained by
bifurcation analysis of the model using computer simulation. The solid lines show the observable inflammation levels given the external stimulus. This model
analysis indicates the characteristic features of inflammation in AD patients (here defined by high pH or lower LEKTI): the levels of external stimulus (x-axis) that
lead to the outbreak of inflammation are lower in AD patients than in healthy controls (shown by arrows), and the external stimulus has to be reduced further in AD
patients (shown by arrowheads) to obtain an inflammation-free status. (e) Microarray data of AD and healthy skin samples were analyzed to create an index for the
level of PAR2-mediated inflammation. AD patients showed higher scores compared with healthy controls (HC; box plot). The microarray results and the model
results were compared to refine the hypothesis.
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Parameter sensitivity analysis syste-
matically investigates which parameters
have large impacts on the system
behavior (Cho and Shin, 2003).
Sensitive parameters, whose small chan-
ges dramatically alter the system
behavior, should be carefully measured
by experiments, whereas ‘‘insensitive’’
parameters are possible targets for
parameter reduction to simplify the
model.
Bifurcation analysis of the AD model
shows that the model captures the
fundamental nature of inflammation:
the level of inflammation increases
abruptly once the external stimulus
exceeds a threshold level (Figure 1d). It
also predicts that stronger and
more persistent inflammation is trig-
gered by smaller stimulus in atopic
conditions (represented by high pH
and low LEKTI) as compared with
healthy skin.
Data analysis for the comparison of data
and model
Disease activity is usually the primary
interest in clinical settings, and therefore
is the main focus of the model–data
comparison. The disease activity is
mostly evaluated by a combination of
multiple qualitative measurements (e.g.,
visual and histological observations) and
quantitative measurements of the con-
centration of key molecules. Full use of
both data for direct comparison with
the model results requires appropriate
data analysis such as multidimensional
analysis.
As the output of the AD model, PAR2-
mediated inflammation, could not be
measured directly, an index created
by multidimensional analysis of
microarray data was used to compare
the model predictions with clinical data
(Figure 1e).
Biological interpretation of the results
Finally, the experimental data and
model predictions are compared and
the results are used to refine the original
hypothesis and deepen our understand-
ing of the system. Inconsistencies
between the model and experimental
results, if found, suggest the need to
further refine the model. If adding extra
components to the model better
explains the experimental data, new
experiments may be attempted to
explore the unidentified mechanism. If
some parameters are critical for fitting
the model to the experimental results,
new experiments may focus on the
mechanism that determines these criti-
cal parameters. Meanwhile, the model
results may identify unnecessary experi-
mental comparisons or time points.
Analysis of the AD model reveals that
feedback regulation of KLK and LEKTI
production mediated by PAR2 is critical
to determine the level of inflammation.
Furthermore, it shows that the balance
between the degradation rates of KLK
and PAR2 and the feedback strength are
the most important factors in determin-
ing the behavior of the system. These
key parameters remain to be experimen-
tally measured to further reveal their
molecular mechanisms.
This iterative cycle of experiments
and modeling is most productive if it
raises biologically meaningful questions
about the mechanisms that maintain
homeostasis and how the disturbances
in these mechanisms lead to disease.
Figure 2 summarizes the combined
approach of experiment and modeling.
IMPACT: WHAT BENEFITS CAN SKIN
RESEARCH EXPECT FROM
MATHEMATICAL MODELING?
This section examines possible applica-
tions of the modeling approach to basic
and clinical problems.
Revealing the dynamic mechanisms of the
skin
Skin is a dynamic organ and its home-
ostasis is maintained through the regula-
tion of the differentiation, proliferation,
migration, and death of various cells.
Here we consider three dynamic sys-
tems in the skin: epidermis, hair folli-
cles, and the skin immune system.
Epidermis. The epidermis is a multi-
layered epithelium composed largely of
keratinocytes, continually renewed by dif-
ferentiated cells in the basal layer. Kerati-
nocytes show terminal differentiation from
stratum granulosum to stratum corneum,
Hypothesis
a
b d
e
f
c
Comparison
Model
results
Model
development
Mathematical model
Designs of
experiments
Model
analysis
Data
analysis
Knowledge
of disease
Clinical and experimental settings
Experimental
results
Experiments
Figure 2. An integrative approach of experiments and modeling for skin disease. (a) Based on the available experimental data and knowledge of the disease in
question, a hypothesis is formed and systems to be modeled are identified. (b) A mathematical model to test the hypothesis is developed, by describing clinical and
experimental data on key components by mathematical terms. (c) Experiments are designed to obtain data required to determine key parameters and to be
compared with the model. The feasibility of experiment is a major factor that constrains the model structure. (d) The developed model is mathematically analyzed
to provide a set of model results. Iterations of model development and model analysis refine the model, whose results should be compared with experimental
results. (e) Raw experimental data are analyzed and mined for direct comparison with the model results. (f) The model results and the experimental results are
compared, and the results are used to refine the original hypothesis and the mathematical model and to identify critical experiments. These processes are repeated
to obtain a better understanding of the disease mechanisms.
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where the skin permeability barrier is
formed (Cork et al., 2009; Jepps et al.,
2013). Epidermal homeostasis is abrogated
in inflammatory diseases involving the
epidermis (Lowes et al., 2007; Cork
et al., 2009), where dysregulation of the
homeostatic mechanisms of keratinocytes
can contribute to inflammation, which, in
turn, may alter the differentiation of
keratinocytes. Mathematical modeling is
effective for revealing those complex
interacting relationships, and has been
applied to psoriasis, as well as our work
on AD described in our previous section,
with potentially important clinical
consequences. Psoriasis is characterized
by excessive growth and aberrant
differentiation of keratinocytes and
inflammation in the epidermis and
dermis. The morphology of psoriatic skin
has been analyzed by a geometric model
(Iizuka et al., 1997) and a computational
model of epidermal homeostasis (Grabe
and Neuber, 2007). Keratinocytes in
psoriatic lesions contribute to
inflammation by producing cytokines and
chemokines such as IL-8, CCL20, and
S100A8/A9 that recruit neutrophils and
lymphocytes into the lesions (Lowes
et al., 2007; Strange et al., 2010). The
polarization of helper T cells in psoriatic
lesions between the T helper types 1 and
17 (Lowes et al., 2007; Perera et al., 2012)
has been addressed by mathematical
modeling (Valeyev et al., 2010).
Lymphocyte-derived cytokines, in turn,
act on keratinocytes to either induce
inflammatory genes or increase
proliferation (Lowes et al., 2007; Pastore
et al., 2008). As a psoriatic lesion is the
manifestation of the interaction between
the dysregulation of keratinocyte
differentiation and the immune system,
clarifying the dynamic interplay between
these two systems, in addition to the
intrinsic control mechanism in each
cellular compartment, is essential and
can be effectively addressed by
mathematical modeling.
Hair follicles. Hair follicles show the
dynamic cycle of epithelial growth (ana-
gen), regression (catagen), and quiescence
(telogen) (Stenn and Paus, 2001).
Understanding of hair growth disorders,
characterized and classified by the
patterns of alteration of the hair cycle,
can be greatly advanced by mathematical
modeling (Al-Nuaimi et al., 2010). A
mathematical model was proposed to
address the feedback control mechanism
from matrix keratinocytes to the dermal
papilla (Al-Nuaimi et al., 2012). Human
hair cycles have been analyzed using an
automaton model that defines the rule of
transition for each hair follicle (Halloy
et al., 2000; Plikus et al., 2011). A
combination of these approaches will
provide new insights into hair growth
disorders.
The immune system: skin and systemic.
Skin is a dynamic immune organ. The
onset of inflammation triggers the flow of
immune cells back and forth between the
skin and the systemic immune systems:
activated keratinocytes and lymphocytes
recruit granulocytes and circulating lym-
phocytes into the skin by producing che-
mokines (Bos et al., 2005; Nestle et al.,
2009); activated dendritic cells migrate to
the draining lymph nodes to prime T cells
(Nestle et al., 2009); and skin-homing
memory T cells traffic to the draining
lymph nodes (Egawa and Kabashima,
2011). During these processes, T cells
differentiate into helper and regulatory T
cells, the pattern of which is thought to
determine the nature of the immune
response (Sakaguchi et al., 2008; Nestle
et al., 2009; Egawa and Kabashima, 2011).
The alteration of the immunological
environment in the skin has significant
impact on the compositions of T cells in
the circulation (Loser et al., 2006; Fujii
et al., 2011). Mathematical modeling is
useful to understand these dynamic events
by revealing the cellular kinetics of
lymphocytes in the skin and systemic
immune systems, depending on their
activation and differentiation status. It has
been used to reveal the mechanisms of the
key steps including T-cell homeostasis
(Thomas-Vaslin et al., 2008), chemotaxis
(Onsum and Rao, 2007), antigen
presentation (Kirschner et al., 2007),
T-cell differentiation (Valeyev et al.,
2010; Hong et al., 2011), and regulatory
T cell–mediated suppression (Feinerman
et al., 2010; Almeida et al., 2012). Further
development of models and experiments
may effectively reveal the regulatory
mechanisms of the immune response by
skin-homing and circulating lymphocytes
and keratinocytes.
Identifying therapeutic targets
The modeling approach provides logical
and mechanistic ways to identify
new therapeutic targets by revealing
disease-related mechanisms and deter-
mining the possible effects of a thera-
peutic intervention that act on critical
points to normalize the dysregulation of
the system. Although not discovered by
the modeling approach, cyclosporin is a
drug that normalizes the dysregulation
of T cell–mediated immune response in
autoimmune diseases by blocking the
translocation of NFAT (nuclear factor of
activated T-cells) to the nucleus in T
cells to suppress the transcription of Il2,
which is the key molecule for the
positive feedback in T-cell activation
as IL-2 production leads to the tissue
damage in autoimmune disease
(Sigal and Dumont, 1992; Ferraccioli
et al., 2005).
Classifying skin disease and identifying
the common control mechanisms
Mathematical description of the spatial
pattern of skin eruptions might help us
understand the control mechanisms of
skin diseases, in which the global pat-
tern of skin eruption is important for
diagnosis. For example, the typically
observed pattern in erythema gyratum
repens has been reproduced by a
diffusion equation model (Gilmore,
2005). This may reveal the underlying
molecular control mechanism of the
pattern formation (Rogers and Schier,
2011). Similarities in the pattern of
eruptions, observed in different
diseases, may suggest common under-
lying molecular mechanisms. For
example, Staphylococcal scaled skin
syndrome and pemphigus foliaceus
show similarities in their clinical and
histological manifestations, attributable
to the common molecular mechanism
of Desmoglein-1 cleavage (Stanley and
Amagai, 2006).
Using this approach, it might be
possible to classify skin diseases by the
underlying control mechanisms of the
pattern formation, as revealed by math-
ematical modeling. A first step for this
ambitious project would be to system-
atically analyze the patterns of eruptions
of various skin diseases, and identify
the clusters of eruptions with a common
underlying control mechanism. This
new classification may help to
explain the different phenotypic
manifestations of the same disease
(Loscalzo et al., 2007) and will also
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allow mathematical models for a
particular disease to be rationally exten-
ded to other diseases with common
molecular mechanisms.
TOWARD SUCCESSFUL USE OF A
MATHEMATICAL PERSPECTIVE IN
SKIN RESEARCH
Skin research may provide a prototypic
framework for the mathematical model-
ing approach that can be used in a wide
range of biomedical fields, as skin has
the advantage of accessibility compared
with other organs and there is a wealth
of accumulated knowledge about skin
disease.
Main challenges
There are major challenges, for both
experiments and modeling, toward the
successful development of the modeling
approach in skin research.
Complexity of the skin: difficulty of
experimental measurements. Given the
anatomical and functional complexity of
the skin, it is challenging to establish
feasible experimental systems to quantita-
tively measure the activity of the
components that are modeled (Pasonen-
Seppanen et al., 2001). If all the regulatory
mechanisms are confined to the
epidermis, organotypic culture is the
system to be used. Otherwise, samples
from patients or animal disease models
will be required. The proteins of the
cornified layer of the epidermis can be
analyzed by ELISA using tape stripping
samples (Kezic et al., 2012), or by
proteomics (Broccardo et al., 2011).
Two-photon microscopy may provide
data for cellular kinetics of lymphocytes
in the skin (Egawa and Kabashima, 2011).
The modeling approach may further
promote the development of novel
technologies for quantitative measure-
ments. Studies on inflammatory skin dis-
ease require us to analyze the dynamic
interaction between the epidermis/dermis
and the immune system. Mathematical
modeling will inevitably be effective for
many immunological/dermatological pro-
blems, where there are no experimental
means to precisely measure the activities
of immune cells and the response of
keratinocytes in a real-time manner.
Confirmation bias—a pitfall of the
iterative approach by experiment and
model. The second challenge addressed
here is fundamental in the modeling
approach for complex biological problems
—how to avoid confirmation bias when
models are developed and when model
results are compared with experimental
results. Confirmation bias is defined as the
seeking or interpreting of evidence in ways
that are partial to existing beliefs, expecta-
tions, or a hypothesis in hand (Nickerson,
1998). It is a bias behind our research
practice, not a statistical bias, and is
introduced not only by our own nature
but also by the peer review process
(Goodyear-Smith et al., 2012). This
problem has never been discussed in the
context of mathematical modeling as far as
the authors know, although it is
significantly relevant. The process of
model validation harbors the risk of
confirmation bias: if one pursues only the
compatibility between experimental and
model results, the original hypothesis can
stand without scientific basis, leading to
false-positive results. Confirmation bias
can have an even larger impact in the
iterative cycle of experiments and
modeling, as it may affect the choice of
components included in the model and
the choice of experimental data to
compare with the model results. This
problem occurs because the number of
components to be modeled should be
severely limited compared with the
number of molecules/cells involved in a
disease process, and also because
disease-related data are generally com-
plex and multidimensional with many
measurements. From a viewpoint of
dynamical systems theory, this problem
is deeply related to model invalidation,
which emphasizes the importance of
invalidating models, rather than valida-
ting them, by excluding models that are
incompatible with available data
(Anderson and Papachristodoulou, 2009).
To decrease the risk of confirmation
bias, multiple models should be
constructed and used depending on the
experimental data available. Ideally, the
models should not rely on the validation
by experiments but serve for excluding
unrealistic models and unnecessary
experiments by model invalidation. Wher-
ever possible, hypothesis-free and data-
driven approach is also recommended to
compare experimental and model results.
Visualization of experimental data by
multidimensional analysis may be useful
for addressing the biological relevance of
the findings.
Future perspectives
The modeling approach has a huge
potential to strengthen the power of
conventional experimental approaches
in dermatology. The quantitative and
predictive power of the mathematical
sciences will allow skin research to fully
benefit from quantitative measurements
by experiments. Use of mathematical
models to reveal the underlying
mechanisms for dynamic disease pro-
cesses, together with a systematic
approach to the combination of qualita-
tive/quantitative data, enhanced by
future technological advances for experi-
mental measurement, will advance skin
research in the postgenomic era.
This article has provided a view on
skin disease modeling mainly from a
control engineering perspective. For
more general discussions on the systems
approach in medicine, see other reviews
(Vodovotz et al., 2008; Auffray et al.,
2009; Clermont et al., 2009; Hunter and
Viceconti, 2009; Popel and Hunter,
2009; Yu et al., 2011). There have
been many research activities using
mathematical modeling in dermato-
logy, including geometry-based models
(O’Toole, 2010), diffusion-based models
(Gilmore, 2005), finite element
models (Flynn et al., 2011), biophysical
models (Ciarletta et al., 2011), and che-
mical reaction network models (Valeyev
et al., 2010; Tanaka et al., 2011).
The most important initial step for
successful application of mathematical
modeling to skin disease is continuous
and constant interaction between
researchers in dermatology and those
in engineering and physical sciences,
and thus skin researchers are encour-
aged to be involved in cross-disciplinary
research (Goldsmith, 2012). Nonbio-
logical disciplines currently involved in
cross-disciplinary research in biome-
dicine include engineering, mathema-
tics, statistics, physics, chemistry, and
computer science. The best mixture of
expertise from different disciplines
varies depending on the nature of the
biological problem. In order to obtain
findings that enrich basic and clinical
dermatology, skin biologists and
dermatologists are needed to drive and
orient the cross-disciplinary research to
address the most fundamental biological
and medical problems.
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